arrow
C

Cristina Marta Del-Ben

Université Paris Saclay
H指数:45
被引数:7,374

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IQ and subclinical psychosis: The role of psychosocial stressors and core schemata

智商与亚临床精神病:心理社会压力源和核心图式的作用

2026-07-010
PRE
Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation

小剂量甲氨蝶呤作为通过星形胶质细胞和神经免疫调节治疗精神分裂症的潜在疗法

2025-07-310
PRE
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Levels
2025-03-010
OAAI
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors

通过病前恶化和暴露于环境危险因素,在精神病发作时的认知表现

2025-02-050
PRE
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques

停止使用大麻和精神障碍的风险: 来自第一集病例对照eu-gei WP2研究的病例对照分析: l'arr ê tde l'utilisation du Cannabis et le risque de situes psychotiques: 分析cas-témoins tirée de l'étude cas-témoins eu-gei WP2 centrée sur les premiers é p psychotiques

2025-01-150
PRE
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies

在eu-gei病例对照和英国Biobank研究中,精神分裂症遗传负荷和大量使用大麻对精神病风险的影响

2024-12-060
OAAI
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings
2024-11-220
OAAI
The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis

多基因风险评分和儿童逆境对首发精神病的跨诊断症状维度的影响: 精神病情感途径的证据

2024-10-260
OAAI
Methylomic signature of current cannabis use in two first-episode psychosis cohorts

在两个首发精神病队列中当前使用大麻的甲基特征

2024-10-160
OAAI
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study
2024-05-244
OAAI